China's Shanghai Pharmaceutical Holding Co. announced it may bid for Germany's Stada Arzneimittel AG, and compete against buyout firms Bain and Cinven, which reportedly made a joint offer of almost $6 billion, according a Reuters story.
The Chinese company said in a filing it had recently discussed the matter with "a couple of financial investors," but it had not made a concrete offer yet.
Read the full story